Neumol Pediatr 2022; 17 (3): 92 - 96 Revista Neumología Pediátrica | Contenido disponible en www.neumologia-pediatrica.cl 96 Terapias biológicas y tuberculosis en pediatría 14. NORMA-TECNICA-TUBERCULOSIS-2021.Ministerio de Salud.Chile.[ Internet].2021 [cited 2022 january 14]. Disponible en: https://diprece.minsal.cl/programas-de-salud/ programas-enfermedades-transmisibles/informacion-al-profesional-tuberculosis/. 15. AmericanAcademy of Pediatric. [Tuberculosis].In: Kimberlin DW, Brady MT, Jackson MA el al.Red Book:2015.Report of the Committee on Infectious Diseases.30th ed.Elk Grove Villagr, IL: American Academy of Pediatrics; 2015:[804830]. 16. Venturini E., Tersigni C., Chiappini E., de Martino M. and Galli L. Optimizing the management of children with latent tuberculosis infection. Expert Review of Anti-inefective Therapy 2017. 15(4):341-349. Disponible en: https://doi.org/10 .1080/14787210.2017.1279541. 17. Seddon JA., Paton J., Nademi Z. et al. The impact of BCG vaccination on tuberculin skin test responses in children is age dependent: evidence to be considered when screening children for tuberculosis infection. Thorax 2016;71:932–939. DOI:10.1136/thoraxjnl-2015-207687. 18. Barbosa J., Rossi K., Silva C. el al. Latent tuberculosis infection screening in juvenile idiopathic arthritis patients preceding anti-TNF therapy in a tuberculosis high-risk country. Rev Bras Reumatol.2017;57(5):392–396. Disponible en: http://dx.doi.org/10.1016/j.rbre.2016.11.004. 19. Kane SV, Acquah LA. Placental transport of immunoglobulins: a clinical review for gastroenterologists who prescribe therapeutic monoclonal antibodies to women during conception and pregnancy. Am J Gastroenterol 2009;104:22833. DOI: 10.1038/ajg.2008.71. 20. Julsgaard M, Christensen LA, Gibson PR, et al. Concentrations of adalimumab and infliximab in mothers and newborns, and effects on infection. Gastroenterology 2016;151:110-9. 21. Murashima A, Watanabe N, Ozawa N, et al. Etanercept during pregnancy and lactation in a patient with rheumatoid arthritis: Drug levels in maternal serum, cord blood, breast milk and the infant’s serum. AnnRheumDis 2009;68:17934. DOI: 10.1136/ard.2008.105924 22. Cheent K., Nolan J., Shariq S. el al. Case Report: Fatal case of disseminated BCG infection in an infant born to a mother taking infliximab for Crohn's disease. J Crohn´s Colitis. 2010 Nov;4(5):603-5. DOI: 10.1016/j.crohs.2010.05.001. Disponible en: https://doi.org/10.1016/j.crohns.2010.05.001 23. Mahadevan U, Martin C, Kane SV, et al. Do infant serum levels of biologic agents at birth correlate with risk of adverse outcomes? Results from the PIANO registry.Gastroenterology. 2021 March:160(4): 1131–1139. DOI :10.1053/j.gastro.2020.11.038. 24. Berthelsen BG, Fjeldsøe-Nielsen H, Nielsen CT, et al. Etanercept concentrations in maternal serum, umbilical cord serum, breast milk and child se rum during breastfeeding. Rheumatology 2010;49:2225–2227 DOI:10.1093/rheumatology/keq185. 25. Carina Götestam Skorpen el al. The EULAR points to consider for use of antirheumatic drugs before pregnancy, and during pregnancy and lactation. Ann Rheum Dis 2016;75:795–810. DOI:10.1136/annrheumdis-2015-208840. 26. Asmaa Bettagy el al. Biologics During Pregnancy and Breastfeeding Among Women With Rheumatic Diseases:- Safety Clinical Evidence on the Road.Front. Pharmacol ; 2021. Sec.Obstetric and Pediatric Pharmacology. 27. Nguyen GC, Seow CH, Maxwell C, et al. The Toronto Consensus Statements for the management of inflammatory bowel disease in pregnancy. Gastroenterology 2016;150:734-57.e1 DOI: 10.1053/j.gastro.2015.12.003. Epub 2015 Dec 11. 28. van der Woude CJ, Ardizzone S, Bengtson MB, et al. The second European evidenced-based consensus on reproduction and pregnancy in inflammatory bowel disease. J Crohns Colitis 2015;9:107-24. 29. American Academy of Pediatrics.[ Immunization in special clinical circumstances ] In: Kimberlin DW, BradyMT, Jackson MA, Long SS, eds. Red Book: 2018 Report of the Committee on Infectious Diseases. 31st ed. Itasca, IL: American Academy of Pediatrics; 2018: 85-87.
RkJQdWJsaXNoZXIy MTYwMjk1